Monthly Archives: July 2020

Rett syndrome Independence Day Gets (hopefully) a Little Closer! Trofinetide Reopens- An Interview with Dr. Jim Youakim

Posted on July 6, 2020 by melelllan

On Saturday June 27, I had the pleasure of speaking with Dr. Jim Youakim, Vice President of Research and Development, to get an update on the trofinetide trial and it’s recent reopen. Bill Keller, Executive Director of Patient Advocacy, joined … Continue reading →

Posted in Acadia, clinicaltrials.gov, FDA, Neuren Pharmaceuticals, Rett Research, Rett Syndrome, Trail to a Texas Trial, Trofinetide, Trofinetide Phase III, Uncategorized | Tagged , , , , , , , | Leave a comment